Back to Primary literature
Primary-literature peptidemedium evidence

PEPDIA-PLP-003360

P9

Aliases: P9

Normalized sequence

YVRHHHYVRHHH

12 amino acids

Release PepDiana-V1-20260620

3

Activity records

1

Source papers

2

Positive

1

Negative / threshold

Versioned scientific descriptors

Physicochemical properties and standard representations

calculated sequence and structure

Reported properties

No separate physicochemical property was reported in the primary-literature identity record. PepDiana release values are shown as computed properties.

Computed properties

physchem-20260620

Molecular weight

1677.8309 Da

Molecular formula

C76H104N30O15

Theoretical pI

9.9866

Net charge at pH 7

2.2811

GRAVY

-1.8667

Instability index

77.8833

Aromaticity

0.1667

Topological polar surface area

719.76 Ų

cLogP

-4.739

Hydrogen-bond donors

27

Hydrogen-bond acceptors

23

Rotatable bonds

49

Method: PepDiana sequence/structure descriptor pipeline

Tool: Biopython+RDKit · Biopython 1.85; RDKit 2024.09.6

Calculated: 2026-06-20T11:01:38.358971+00:00

Assumptions: ph=7; termini=free N-terminus and free C-terminus for simple linear peptides; stereochemistry=standard L-amino acids; smiles_length_limit=200

Sequence representations

representations-20260620

ProForma 2.0

validated simple linear

YVRHHHYVRHHH

HELM 2.0

validated simple linear

PEPTIDE1{Y.V.R.H.H.H.Y.V.R.H.H.H}$$$$V2.0

Canonical SMILES

validated

CC(C)C(NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]cn1)C(=O)O)C(C)C

Isomeric SMILES

validated

CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O

Paper-level observations

Experimental evidence grouped by activity

Other 2 records

PMC10126514

2 observations
OtherAnti-AggregationPositive observation
Record detail

Figure 4: compared with the Aβ positive control group, the fluorescence intensity of P9 and P12 polypeptides has increased, but the difference is not statistically significant (p > 0.05), indicating that P9 and P12 have no inhibitory effect on Aβ aggregation.

Measure
percent_inhibition
Value
fluorescence intensity increased, no inhibitory effect (p>0.05)
Target
Aβ1-42
Assay
Not reported by source
Source publication
Toxicity 1 records

PMC10126514

1 observations
ToxicityCytotoxicNegative / threshold
Record detail

Figure 3A: cell viability of P9 at a lower concentration (6.25 uM) began to decrease significantly (p < 0.05), and the cell viability of 25, 50, 100, and 200 uM also decreased significantly, with extremely significant differences (p < 0.01).

Measure
cell_viability
Value
cell viability decreased significantly at 6.25 uM (p<0.05), and at 25, 50, 100, 200 uM (p<0.01)
Target
Rattus norvegicus
Assay
Not reported by source
Source publication

Citation and release provenance

Cite this identity as PepDiana record PEPDIA-PLP-003360, release PepDiana-V1-20260620. Experimental observations retain their paper, mention, and activity-record identifiers.

Record updated: 2026-06-22T07:14:26.229247+00:00